Premier Biomedical, Inc. (BIEI)

Premier Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0	0	0	0	0	0.07
Cash & Cash Equivalents	0	0	0	0	0	0.07
Cash Growth	-	-	-	-	-	-18.00%
Receivables	0	0	0	0	0	0
Inventory	0	0	0	0	0	0.01
Other Current Assets	0	0	0	0	0	0.01
Total Current Assets	0	0	0	0	0	0.09
Property, Plant & Equipment	0	0	0	0	0	0.01
Other Long-Term Assets	-0	-0	0	0	0	0
Total Long-Term Assets	0	0	0	0	0	0.01
Total Assets	0.01	0.01	0	0	0	0.1
Accounts Payable	0	0	0	0.22	0.22	0.22
Deferred Revenue	0	0	0	0	0	0.06
Current Debt	0.57	0.57	0.44	0.44	0.42	0.16
Other Current Liabilities	1.92	1.92	1.85	1.6	1.58	1.49
Total Current Liabilities	2.49	2.49	2.28	2.25	2.22	1.93
Total Liabilities	2.49	2.49	2.28	2.25	2.22	1.93
Total Debt	0.57	0.57	0.44	0.44	0.42	0.16
Debt Growth	29.94%	29.94%	0.32%	4.26%	160.15%	-48.09%
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Retained Earnings	-17.86	-17.86	-17.65	-17.6	-17.56	-17.1
Comprehensive Income	-0.01	-0.01	-0.01	-0.01	-0.01	0
Shareholders' Equity	-2.48	-2.48	-2.28	-2.25	-2.22	-1.83
Total Liabilities and Equity	0.01	0.01	0	0	0	0.1
Net Cash / Debt	-0.56	-0.56	-0.44	-0.44	-0.42	-0.09
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Working Capital	-2.49	-2.49	-2.28	-2.25	-2.22	-1.84
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.03

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.